Search | Page 3 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Myelodysplastic syndromes: a challenging disease for patients and physicians

    ... the treatment carries a high risk of rapidly developing neutropenia and thrombocytopenia . Several promising drugs are ...

    Research Article last updated 07/31/2012 - 1:58pm.

  2. Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes

    ... MDS can present with varying degrees of anemia , neutropenia , and thrombocytopenia , and at presentation can range ...

    Research Article last updated 07/31/2012 - 1:03pm.

  3. The clinical safety of lenalidomide in multiple myeloma and myelodysplastic syndromes

    ... management, including dose modifications for neutropenia and thrombocytopenia , and venous thromboembolism ...

    Research Article last updated 11/16/2011 - 2:10pm.

  4. Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades.

    ... BACKGROUND: Persistent neutropenia associated with severe aplastic anemia (SAA) is an ...

    Research Article last updated 10/11/2011 - 5:58pm.

  5. Resources

    ... MDS results in low blood counts, such as anemia neutropenia and thrombocytopenia and the associated symptoms. ...

    Topic section last updated 10/30/2017 - 11:40am.

  6. Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes.

    ... 3/4 non-hematologic adverse events included febrile neutropenia (22% of patients), other infection (11%), pulmonary (11%), ...

    Research Article last updated 10/01/2012 - 9:58am.

  7. Effects of azacitidine compared with conventional care regimens in elderly (≥ 75 years) patients with higher-risk myelodysplastic syndromes.

    ... supportive care (67%). Grade 3-4 anemia , neutropenia , and thrombocytopenia with AZA vs CCR were 13% vs 4%, ...

    Research Article last updated 10/11/2011 - 5:58pm.

  8. The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes.

    ... but with similar degrees of anemia and neutropenia , transfusion requirements, and similar incidences of ...

    Research Article last updated 06/20/2013 - 11:02am.

  9. Phase I study of oral azacitidine in myelodysplastic syndromes, chronic myelomonocytic leukemia, and acute myeloid leukemia

    ... (12.2%), nausea (7.3%), vomiting (7.3%), febrile neutropenia (19.5%), and fatigue (9.8%). Azacitidine exposure increased ...

    Research Article last updated 10/11/2011 - 5:58pm.

  10. 5-Azacitidine efficacy and safety in patients aged >65 years with myelodysplastic syndromes outside clinical trials

    ... grade 3-4 thrombocytopenia and 30% grade 3-4 neutropenia ). Our results suggest that advanced age should not preclude ...

    Research Article last updated 06/15/2012 - 2:13pm.